Medindia

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Function Compared to Budesonide Alone

TITAN study results presented at CHEST meeting represent one of few asthma studies to examine African American patients exclusively SYMBICORT is a combination asthma medication that contains both an ...
Fierce Healthcare

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
FiercePharma

Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
FierceBiotech

Press Release: AstraZeneca Announces Symbicort Is Now Available In The U.S.

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...
Monthly Prescribing Reference

FDA Approves Inhaler Monitoring Device for Symbicort

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...
FierceBiotech

EPO Announces Symbicort European COPD Use Patent Decision

AstraZeneca today announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent covering the use of Symbicort (formoterol and ...
Business Insider

Symbicort® Turbuhaler® now approved by Health Canada for use in mild persistent, moderate, or severe asthma

MISSISSAUGA, ON, Sept. 30, 2019 /CNW/ - AstraZeneca Canada announced today that Health Canada has approved the expanded use of Symbicort ® Turbuhaler ® (budesonide ...
Monthly Prescribing Reference

Smartinhaler Sensor for Symbicort Will Be Available Over-the-Counter

The Smartinhaler sensor is a device installed onto a patient's inhaler to monitor and promote asthma and COPD medication adherence. Adherium announced that the Food and Drug Administration (FDA) has ...
PharmaTimes

EU patent for AstraZeneca’s Symbicort in COPD revoked

A week after submitting its combination asthma drug Symbicort to be marketed in the USA as a treatment for chronic obstructive pulmonary disease, the firm has been told that its patents for that ...
health.economictimes.indiatimes

AstraZeneca gets marketing nod for asthma drug Symbicort

Mumbai: AstraZeneca Pharma India today said it has received marketing authorisation from the Drug Controller General of India (DCGI) for Symbicort, a medicine used for treatment of asthma. "We have ...
FiercePharma

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Functio

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...